torcetrapib has been researched along with pravastatin in 2 studies
Studies (torcetrapib) | Trials (torcetrapib) | Recent Studies (post-2010) (torcetrapib) | Studies (pravastatin) | Trials (pravastatin) | Recent Studies (post-2010) (pravastatin) |
---|---|---|---|---|---|
273 | 28 | 83 | 3,575 | 1,036 | 816 |
Protein | Taxonomy | torcetrapib (IC50) | pravastatin (IC50) |
---|---|---|---|
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.1452 | |
Insulin receptor | Rattus norvegicus (Norway rat) | 0.0056 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0056 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0254 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Einecke, D | 1 |
Bots, ML; Doevendans, PA; Grobbee, DE; Jukema, JW; Kastelein, JJ; Kuivenhoven, JA; Regieli, JJ; van der Graaf, Y; Zwinderman, AH | 1 |
2 other study(ies) available for torcetrapib and pravastatin
Article | Year |
---|---|
[High lowering of lipids can melt coronary plaques -- is coronary disease reversible?].
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Controlled Clinical Trials as Topic; Coronary Disease; Coronary Vessels; Drug Therapy, Combination; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Placebos; Pravastatin; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Sulfonamides; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2006 |
CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction.
Topics: Alleles; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Coronary Artery Disease; Genotype; Humans; Male; Pharmacogenetics; Polymorphism, Genetic; Pravastatin; Predictive Value of Tests; Quinolines; Randomized Controlled Trials as Topic | 2008 |